I may add that it is still a convenience for some patients in taking the medicine. Overall good improvement and good for CSl looking after the patients.
- Forums
- ASX - By Stock
- News: CSL Csl Behring Receives FDA Approval For Hizentra® (Immune Globulin Subcutaneous <Origin...
CSL
csl limited
Add to My Watchlist
1.04%
!
$257.97

I may add that it is still a convenience for some patients in...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$257.97 |
Change
2.660(1.04%) |
Mkt cap ! $123.6B |
Open | High | Low | Value | Volume |
$258.12 | $258.26 | $257.91 | $5.851M | 22.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12 | $257.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$258.08 | 7 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1199 | 306.370 |
1 | 52 | 300.000 |
1 | 36 | 277.350 |
2 | 10 | 271.110 |
1 | 777 | 271.000 |
Price($) | Vol. | No. |
---|---|---|
236.250 | 199 | 3 |
237.260 | 34 | 1 |
237.540 | 2826 | 1 |
239.990 | 673 | 9 |
242.540 | 409 | 1 |
Last trade - 10.00am 22/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |